Cathay Biotech (SH:688065) Zheng Quan Zhi Xing·2025-08-01 16:36Core Points - The document outlines the information disclosure system of Shanghai Kasei Biotechnology Co., Ltd, aiming to enhance the quality and standardization of information disclosure, ensuring that information is disclosed truthfully, accurately, completely, timely, and fairly to protect the rights of the company, shareholders, and other stakeholders [1][2][3]. Group 1: General Principles - The information disclosure obligations apply to the company, its subsidiaries, and major shareholders holding more than 5% of shares, including directors, senior management, and relevant departments [2][3]. - Information disclosure must adhere to principles of openness, fairness, and equal treatment of all shareholders, prohibiting selective disclosure [3][4]. Group 2: Disclosure Obligations - Information that may significantly impact the trading price of the company's stock must be disclosed in a timely manner, including both regular and temporary reports [3][11]. - The company must ensure that disclosed information is truthful, accurate, complete, and clear, avoiding misleading statements or omissions [4][5]. Group 3: Reporting Procedures - Regular reports include annual, semi-annual, and quarterly reports, which must be disclosed within specified timeframes after the end of the respective periods [8][9]. - Temporary reports must be issued immediately upon the occurrence of significant events that could affect stock prices, detailing the event's cause, current status, and potential impact [11][12]. Group 4: Media and Publication - Information must be disclosed on the Shanghai Stock Exchange website and other approved media, ensuring that the public has access to the information [7][55]. - The company may also publish information on its website and other public media, but not before the designated disclosures [25][26]. Group 5: Confidentiality and Penalties - Individuals with access to undisclosed information must maintain confidentiality and are prohibited from trading the company's stock based on insider information [26][27]. - Violations of disclosure regulations may result in penalties, including disciplinary actions against responsible individuals and potential legal consequences [27][28].